Curcumin is the main bioactive component present in the rhizomes of Curcuma longa Linn (turmeric) [
56]. Curcumin is a bioactive phenol exhibiting anti-inflamatory, antioxidant, tissue protective, chemoprotective, antiviral and immunomodulatory properties. Curcumin also presents a broad spectrum of antibacterial actions including bacterial membrane disruption, disruption of biofilm formation and exerts potent antioxidant effects by scavenging reactive oxygen species (ROS) [
56]. Studies in animals revealed low toxicity, demonstrating good tolerability of daily doses between 4000 and 8000 mg [
57]. Curcumin promotes cell proliferation and migration by activating growth factor signaling pathways, such as the epidermal growth factor receptor (EGFR) pathway, and modulating the expression of extracellular matrix (ECM) components [
57]. Fu et al., [
58] reported that mices treated with curcumin-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) (PCEC) fibers exhibited faster re-epithelialization and blood vessel formation as well as an increase in collagen deposition over time [
57,
58]. Ranjbar-Mohammadi et al., [
59] demonstrated that curcumin-loaded poly(ε-caprolactone)/gum tragacanth (PCL/GT/Cur) electrospun fibers increased collagen content and accelerated the wound healing process in diabetic male Sprague-Dawley rats [
57,
59]. In a comparative study utilizing a skin incision model, it was observed that curc umin facilitated complete epithelial repair, promoted angiogenesis during the proliferative phase of wound healing, and accelerated wound closure [
60]. Curcumin possesses potent anti-inflammatory properties by inhibiting the activity of pro-inflammatory mediators, such as cyclooxygenase-2 (COX-2), interleukin-1 (IL-1), interleukin-8 (IL-8) tumor necrosis factor-1 (TNF-1), matrix metalloprotease 9 (MMP-9) and matrix metalloprotease 3 (MMP-3) [
60]. The ability of curcumin to inhibit the function of NF-(κ)B (Nuclear factor kappa B), a regulatory protein central to inflammatory responses initiation, is also remarkable [
60]. By attenuating inflammation, curcumin promotes a conducive microenvironment for optimal wound healing, and falls under class IV of the biopharmaceutical classification system, characterized by low solubility and poor permeability [
57,
60,
61]. These attributes contribute to a diminished absorption, limited bioavailability, and stability concerns. Additionally, curcumin undergoes rapid metabolism at specific intervals. To address these challenges, various formulations have been explored, such as nanoparticles, liposomes, nanogels, nanoemulsions, and the use of adjuvants and nanocrystals, reporting promising results in promoting wound healing in patients with acute wounds, chronic wounds, and burns [
60,
62].